Inventor · disambiguated record
Gary E. L. Brandt
Also filed as: BRANDT GARY E · BRANDT GARY E L
22 granted patents·204 citations·filing 2016–2023
96Inventor score
Files withTHERAVANCE BIOPHARMA R&D IP LLC22
Top patents by PatentIndex Score
22 records- 0198US10526330B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jan 7, 2020·15 cites·13 claims
- 0298US10208040B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 19, 2019·24 cites·31 claims
- 0398US10196393B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 5, 2019·24 cites·12 claims
- 0498US10100049B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Oct 16, 2018·28 cites·17 claims
- 0597US11420965B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Aug 23, 2022·3 cites·18 claims
- 0697US10550118B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 4, 2020·13 cites·10 claims
- 0797US10519153B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Dec 31, 2019·16 cites·22 claims
- 0897US10392386B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 27, 2019·19 cites·10 claims
- 0997US9725470B2Substituted naphthyridines as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Aug 8, 2017·27 cites·19 claims
- 1096US10988470B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R & D IP LLC·Filed 2020·Granted Apr 27, 2021·3 cites·19 claims
- 1196US10562894B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 18, 2020·7 cites·19 claims
- 1296US10308646B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jun 4, 2019·11 cites·32 claims
- 1394US11453668B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Sep 27, 2022·2 cites·20 claims
- 1494US10913740B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 9, 2021·5 cites·18 claims
- 1593US11299492B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Apr 12, 2022·2 cites·13 claims
- 1693US11254669B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 22, 2022·3 cites·17 claims
- 1792US10954237B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 23, 2021·2 cites·18 claims
- 1889US12358931B23-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Jul 15, 2025·0 cites·5 claims
- 1988US12172994B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 2084US11878977B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Jan 23, 2024·0 cites·5 claims
- 2181US11667637B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Jun 6, 2023·0 cites·19 claims
- 2279US11718616B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Aug 8, 2023·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Gary E. L. Brandt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →